Job title: Clinical Biomarker Lead, ImmunoOncology, Oncology Early Clinical Development
A highly self-motivated, innovative and result-driven Ph.D. scientist with broad knowledge and
experience in immuno-oncology, cancer biology & genetics, and drug development. Technical expert in translational oncology studies (> 10 years of experience) and biomarker assay development (>6 years of experience), with successful experience in executing biomarker strategies in clinical trial settings to support immuno-oncology drug development. Strengths in developing IVD assays, demonstrated by clinical diagnostic industry experience under CLIA and CAP specifications. Expertise in large-scale data analysis/interpretation, and timely execution of projects in a fast paced environment. Experience in sample management, technology assessment, vendor management, KOL collaboration, and partner alliance. Proven scientific track record and excellent communication skills exemplified by various awards, patents, original peer-reviewed publications in prestigious cancer research journals (including Cancer Research, Journal of the National Cancer Institute, Clinical Cancer Research, OncoImmunology) – 8 out of 12 as the first author.
Panel Discussion 4:30 pm
• Tackling assay validation and ensuring markers are clinically applicable for expedited drug development • Finding the specific driver of disease: How far can current technologies take us? • Cost vs quality: Avoiding false positives by finding the right, cost-effective technology for your biomarkerRead more
day: Day One